Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

437
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
437
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

255
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
255
Principles of Drug Action01:24

Principles of Drug Action

5.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.6K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

385
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
385
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Path Planning Capabilities of Automated Guided Vehicles in Dynamic Environments: Multi-Objective PSO and Dynamic-Window Approach.

Biomimetics (Basel, Switzerland)·2024
Same author

An Optimal WSN Node Coverage Based on Enhanced Archimedes Optimization Algorithm.

Entropy (Basel, Switzerland)·2022
Same author

An Analysis Scheme of Balancing Energy Consumption with Mobile Velocity Control Strategy for Wireless Rechargeable Sensor Networks.

Sensors (Basel, Switzerland)·2020
Same author

An Adaptation Multi-Group Quasi-Affine Transformation Evolutionary Algorithm for Global Optimization and Its Application in Node Localization in Wireless Sensor Networks.

Sensors (Basel, Switzerland)·2019
Same journal

Multiphysics Investigation on Thermal Characteristics of Internal Bio-Inspired V-Ribbed Cooling Channels for Outer Rotor PMSM.

Biomimetics (Basel, Switzerland)·2026
Same journal

Smart Logistics Model for Supply Chain Management via Brain-Inspired Geometric Deep Networks.

Biomimetics (Basel, Switzerland)·2026
Same journal

A Systematic Taxonomy of the Sunflower Optimization Algorithm: Variants, Hybridization Strategies, Applications, and Research Directions.

Biomimetics (Basel, Switzerland)·2026
Same journal

Toward a Compositional Theory of Trust in Embodied Intelligence: A QNLP Framework for Modeling Context, Interaction, and Trustworthiness.

Biomimetics (Basel, Switzerland)·2026
Same journal

Empirical Logic for Bio-Inspired Soft Computing: Illustrative Applications in Control Engineering and Cluster Analysis.

Biomimetics (Basel, Switzerland)·2026
Same journal

A Modified Multi-Strategy Dhole Optimization Algorithm and Its Engineering Applications.

Biomimetics (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: May 10, 2025

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.3K

Designing Effective Drug Therapies Using a Multiobjective Spider-Wasp Optimizer.

Trong-The Nguyen1, Thi-Kien Dao1, Van-Thien Nguyen2

  • 1School of Electronic Engineering, Fuzhou Institute of Technology, Fuzhou 350506, China.

Biomimetics (Basel, Switzerland)
|April 25, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces the multi-objective spider-wasp optimizer (MOSWO) for drug design. MOSWO efficiently balances efficacy, safety, and cost, outperforming existing methods in discovering optimal drug therapies.

Keywords:
biologically inspired algorithmsdrug therapy designevolutionary algorithmsmultiobjective spider–wasp optimizerpareto optimization

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.2K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.0K

Related Experiment Videos

Last Updated: May 10, 2025

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.3K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.2K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.0K

Area of Science:

  • Computational pharmacology
  • Bioinformatics
  • Optimization algorithms

Background:

  • Drug design involves balancing efficacy, safety, and cost, which is challenging for conventional methods.
  • Existing optimization techniques struggle with complex trade-offs in multiobjective drug discovery.

Purpose of the Study:

  • To introduce the multi-objective spider-wasp optimizer (MOSWO), a novel algorithm for multiobjective drug design.
  • To address the limitations of current optimization methods in balancing competing drug development objectives.

Main Methods:

  • Developed MOSWO, inspired by spider-wasp cooperative predation dynamics.
  • Integrated adaptive exploration/exploitation mechanisms and dynamic population partitioning.
  • Validated performance on synthetic benchmarks and real-world antiviral/antibiotic therapy case studies.

Main Results:

  • MOSWO demonstrated superior performance compared to NSGA-II, MOEA/D, MOGWO, and MOPSO.
  • Achieved 11% higher hypervolume, 8% lower inverted generational distance, and 9% higher spread scores.
  • Showcased 30% faster convergence and enhanced robustness on noisy biological data.

Conclusions:

  • MOSWO effectively resolves complex trade-offs in multiobjective drug design.
  • The algorithm's adaptability makes it a transformative tool for computational pharmacology.
  • MOSWO offers significant improvements in drug discovery optimization and efficiency.